The kinetic mechanism catalysed by homogeneous rat liver 3α-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs
- 15 September 1991
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 278 (3) , 835-841
- https://doi.org/10.1042/bj2780835
Abstract
Rat liver 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD) (EC 1.1.1.50) is an NAD(P)(+)-dependent oxidoreductase that is potently inhibited at its active site by non-steroidal anti-inflammatory drugs (NSAIDs). Initial-velocity and product-inhibition studies performed in either direction at pH 7.0 are consistent with a sequential ordered Bi Bi mechanism in which pyridine nucleotide binds first and leaves last. This mechanism is supported by fluorescence titrations of the E-NADH complex, and by the failure to detect the binding of either [3H]androsterone or [3H]androstanedione to free enzyme by equilibrium dialysis. Dead-end inhibition studies with NSAIDs also support this mechanism. Initial-velocity studies with indomethacin show that this drug is an uncompetitive inhibitor against NAD+, but a potent competitive inhibitor against androsterone, indicating the ordered formation of an E.NAD+.indomethacin complex. Calculation of the individual rate constants reveals that the binding and release of pyridine nucleotide is rate-limiting and that isomerization of the central complex is favoured in the forward direction. Equilibrium dialysis experiments with [14C]indomethacin reveal the presence of two abortive NSAID complexes, a high-affinity ternary complex corresponding to E.NAD+.indomethacin (Kd = 1-2 microM for indomethacin) and a low-affinity binary complex corresponding to E.indomethacin (Kd = 22 microM for indomethacin). Since indomethacin has a low affinity for free enzyme, the formation of this abortive binary complex does not complicate kinetic measurements which are made in the presence of NAD+, but may contribute to the inhibition of the enzyme by NSAIDs. Using either pro-R-[4-3H]NADH or pro-S-[4-3H]NADH as cofactor, radiolabelled androsterone was formed only when the pro-R-[4-3H]NADH was used, confirming that purified 3 alpha-HSD is a Class A dehydrogenase.Keywords
This publication has 27 references indexed in Scilit:
- Prostaglandin dehydrogenase activity of purified rat liver 3α-hydroxysteroid dehydrogenaseBiochemical and Biophysical Research Communications, 1987
- Inhibition of 3(17).beta.-hydroxysteroid dehydrogenase from Pseudomonas testosteroni by steroidal A ring fused pyrazolesBiochemistry, 1987
- Kinetic studies of rat ovarian 20α-hydroxysteroid dehydrogenaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Characterization of the 3α-hydroxysteroid dehydrogenase of dog prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1977
- Determining the Chemical Mechanisms of Enzyme‐Catalyzed Reactions by Kinetic StudiesPublished by Wiley ,1977
- Partial characterization of the cytosol 3α-hydroxysteroid:NAD(P)+ oxidoreductase of rat ventral prostateBiochemistry, 1975
- 3alpha-Hydroxysteroid Dehydrogenase from Pseudomonas testosteroni: Kinetic Properties with NAD and Its Thionicotinamide AnalogueEuropean Journal of Biochemistry, 1975
- Binding of Salicylate in the Adenosine‐Binding Pocket of DehydrogenasesEuropean Journal of Biochemistry, 1974
- Substrate activation in pyridine nucleotide-linked reactions: illustrations from the steroid fieldProceedings of the Royal Society of London. B. Biological Sciences, 1972
- Stereochemistry of Hydrogen Transfer from Pyridine Nucleotides Catalyzed by Δ4‐3‐Oxosteroid 5β‐Reductase and 3α‐Hydroxysteroid Dehydrogenase from Rat LiverEuropean Journal of Biochemistry, 1970